感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

烧伤感染的诊断标准与治疗指南（2012版）

2012-12-30 中国医师协会烧伤科医师分会 中华烧伤杂志.2012,28(6):401-403.

感染

烧伤感染的诊断标准与治疗指南（2012版）

中文标题：

烧伤感染的诊断标准与治疗指南（2012版）

发布机构：

中国医师协会烧伤科医师分会

发布日期：

2012-12-30

简要介绍：

烧伤感染的诊断标准与治疗指南（2012版）


相关资料下载：
[AttachmentFileName(sort=100, fileName=烧伤感染的诊断标准与治疗指南（2012版）)] GetToolGuiderByIdResponse(projectId=1, id=bebac1c000952883, title=烧伤感染的诊断标准与治疗指南（2012版）, enTitle=, guiderFrom=中华烧伤杂志.2012,28(6):401-403., authorId=null, author=, summary=烧伤感染的诊断标准与治疗指南（2012版）, cover=, journalId=null, articlesId=null, associationId=985, associationName=中国医师协会烧伤科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Sun Dec 30 08:00:00 CST 2012, originalUrl=http://guide.medlive.cn/guideline/5909, linkOutUrl=, content=烧伤感染的诊断标准与治疗指南（2012版）<div><br></div>, tagList=[TagDto(tagId=846, tagName=感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=27, categoryName=烧伤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7309, appHits=374, showAppHits=0, pcHits=4905, showPcHits=2776, likes=292, shares=25, comments=7, approvalStatus=1, publishedTime=Sun Dec 30 08:00:00 CST 2012, publishedTimeString=2012-12-30, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Sun Dec 30 08:00:00 CST 2012, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:59:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=烧伤感染的诊断标准与治疗指南（2012版）)])
烧伤感染的诊断标准与治疗指南（2012版）
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057822, encodeId=58dd105e82236, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:40:18 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003545, encodeId=27341003545b0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b45429717, createdName=ms6000000102688192, createdTime=Thu Jul 29 10:56:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951985, encodeId=b70d95198505, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/ae1f02248c9641b28800bbf70c533b4e/dac9d7b3da4a48cea95d45f3342e39ed.jpg, createdBy=44d42480243, createdName=同（T_T）同, createdTime=Mon Mar 29 09:39:32 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910836, encodeId=78a991083647, content=好资料，下载学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 25 10:53:54 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892249, encodeId=bb0b8922495d, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b515426234, createdName=ms2000000367640122, createdTime=Thu Oct 15 15:52:30 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-10-05 H8888888

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057822, encodeId=58dd105e82236, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:40:18 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003545, encodeId=27341003545b0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b45429717, createdName=ms6000000102688192, createdTime=Thu Jul 29 10:56:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951985, encodeId=b70d95198505, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/ae1f02248c9641b28800bbf70c533b4e/dac9d7b3da4a48cea95d45f3342e39ed.jpg, createdBy=44d42480243, createdName=同（T_T）同, createdTime=Mon Mar 29 09:39:32 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910836, encodeId=78a991083647, content=好资料，下载学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 25 10:53:54 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892249, encodeId=bb0b8922495d, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b515426234, createdName=ms2000000367640122, createdTime=Thu Oct 15 15:52:30 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-07-29 ms6000000102688192

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057822, encodeId=58dd105e82236, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:40:18 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003545, encodeId=27341003545b0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b45429717, createdName=ms6000000102688192, createdTime=Thu Jul 29 10:56:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951985, encodeId=b70d95198505, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/ae1f02248c9641b28800bbf70c533b4e/dac9d7b3da4a48cea95d45f3342e39ed.jpg, createdBy=44d42480243, createdName=同（T_T）同, createdTime=Mon Mar 29 09:39:32 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910836, encodeId=78a991083647, content=好资料，下载学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 25 10:53:54 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892249, encodeId=bb0b8922495d, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b515426234, createdName=ms2000000367640122, createdTime=Thu Oct 15 15:52:30 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-03-29 同（T_T）同

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057822, encodeId=58dd105e82236, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:40:18 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003545, encodeId=27341003545b0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b45429717, createdName=ms6000000102688192, createdTime=Thu Jul 29 10:56:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951985, encodeId=b70d95198505, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/ae1f02248c9641b28800bbf70c533b4e/dac9d7b3da4a48cea95d45f3342e39ed.jpg, createdBy=44d42480243, createdName=同（T_T）同, createdTime=Mon Mar 29 09:39:32 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910836, encodeId=78a991083647, content=好资料，下载学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 25 10:53:54 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892249, encodeId=bb0b8922495d, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b515426234, createdName=ms2000000367640122, createdTime=Thu Oct 15 15:52:30 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-12-25 taken110

    好资料，下载学习！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057822, encodeId=58dd105e82236, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:40:18 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003545, encodeId=27341003545b0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b45429717, createdName=ms6000000102688192, createdTime=Thu Jul 29 10:56:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951985, encodeId=b70d95198505, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/ae1f02248c9641b28800bbf70c533b4e/dac9d7b3da4a48cea95d45f3342e39ed.jpg, createdBy=44d42480243, createdName=同（T_T）同, createdTime=Mon Mar 29 09:39:32 CST 2021, time=2021-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910836, encodeId=78a991083647, content=好资料，下载学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Fri Dec 25 10:53:54 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892249, encodeId=bb0b8922495d, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b515426234, createdName=ms2000000367640122, createdTime=Thu Oct 15 15:52:30 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-10-15 ms2000000367640122

    感谢

    0

相关指南

针对违法药物使用者的HIV感染、病毒性肝炎、性传播疾病和结核病综合预防服务：指南概要

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2012-11-09

2012 第四次全国幽门螺杆菌感染处理共识报告

中华医学会消化病学分会(CSGE,Chinese Society Of Gastroenterology) · 2012-10-05

2012 NICE临床指南：早发性新生儿感染应用抗生素预防和治疗（CG149）

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2012-08-20

丙肝感染，抗病毒治疗和精神健康：欧洲专家共识声明

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2012-08-07

2012 AST指南：器官移植受者中供着来源的真菌感染

美国移植学会(AST,American Society of Transplantation) · 2012-07-13

2012 CDC推荐意见：医护人员和医学生感染乙肝病毒处理规范

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2012-07-06